| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases | 5 | 2022 | 386 | 0.870 |
Why?
|
| Colitis | 6 | 2022 | 164 | 0.830 |
Why?
|
| Cholestasis | 3 | 2022 | 157 | 0.790 |
Why?
|
| Liver | 4 | 2025 | 1857 | 0.510 |
Why?
|
| Colitis, Ulcerative | 4 | 2022 | 213 | 0.500 |
Why?
|
| Liver Transplantation | 5 | 2025 | 1099 | 0.450 |
Why?
|
| Argininosuccinate Lyase | 3 | 2021 | 65 | 0.430 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2025 | 85 | 0.420 |
Why?
|
| Colon | 3 | 2021 | 373 | 0.380 |
Why?
|
| Graft Rejection | 3 | 2024 | 566 | 0.360 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 793 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 311 | 0.310 |
Why?
|
| Trichosporonosis | 2 | 2018 | 8 | 0.290 |
Why?
|
| Liver Cirrhosis | 3 | 2025 | 899 | 0.280 |
Why?
|
| Enterocytes | 2 | 2021 | 75 | 0.270 |
Why?
|
| Biopsy | 6 | 2025 | 1201 | 0.260 |
Why?
|
| Pilomatrixoma | 2 | 2015 | 4 | 0.220 |
Why?
|
| Gastritis | 2 | 2019 | 267 | 0.220 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2021 | 24 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2025 | 96 | 0.220 |
Why?
|
| Child | 19 | 2025 | 25828 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2022 | 141 | 0.200 |
Why?
|
| Fatty Liver | 1 | 2025 | 212 | 0.200 |
Why?
|
| Intestines | 3 | 2021 | 600 | 0.200 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 130 | 0.200 |
Why?
|
| Goblet Cells | 2 | 2021 | 106 | 0.190 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 48 | 0.190 |
Why?
|
| Enterocolitis | 1 | 2022 | 29 | 0.190 |
Why?
|
| Pleural Effusion | 1 | 2022 | 109 | 0.180 |
Why?
|
| Mutation | 4 | 2018 | 6340 | 0.180 |
Why?
|
| Exanthema | 1 | 2022 | 71 | 0.180 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 49 | 0.180 |
Why?
|
| Phytosterols | 1 | 2021 | 27 | 0.180 |
Why?
|
| Amyloidosis | 1 | 2022 | 73 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 2650 | 0.170 |
Why?
|
| Herpesvirus 6, Human | 1 | 2021 | 55 | 0.170 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 45 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 818 | 0.170 |
Why?
|
| Humans | 41 | 2025 | 133147 | 0.170 |
Why?
|
| Bacteroides | 1 | 2021 | 37 | 0.170 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 37 | 0.170 |
Why?
|
| Dipeptides | 1 | 2021 | 64 | 0.170 |
Why?
|
| Ileum | 1 | 2021 | 135 | 0.170 |
Why?
|
| Lymphangioma | 1 | 2020 | 24 | 0.170 |
Why?
|
| Inflammation | 4 | 2021 | 1556 | 0.170 |
Why?
|
| Bifidobacterium | 1 | 2021 | 70 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 37 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2020 | 23 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 224 | 0.160 |
Why?
|
| Interleukins | 1 | 2021 | 130 | 0.160 |
Why?
|
| Mice | 14 | 2022 | 18930 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 239 | 0.160 |
Why?
|
| Adolescent | 13 | 2025 | 20528 | 0.160 |
Why?
|
| Myocarditis | 1 | 2021 | 132 | 0.160 |
Why?
|
| Neuroblastoma | 1 | 2025 | 550 | 0.160 |
Why?
|
| Infant | 11 | 2024 | 13235 | 0.160 |
Why?
|
| Immunocompromised Host | 2 | 2018 | 305 | 0.160 |
Why?
|
| Child, Preschool | 10 | 2025 | 14862 | 0.160 |
Why?
|
| Animals | 18 | 2023 | 36189 | 0.150 |
Why?
|
| Granuloma, Giant Cell | 1 | 2019 | 12 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2021 | 822 | 0.150 |
Why?
|
| Infliximab | 1 | 2019 | 68 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2021 | 312 | 0.150 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2018 | 9 | 0.150 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2018 | 13 | 0.150 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 257 | 0.150 |
Why?
|
| Invasive Fungal Infections | 1 | 2018 | 19 | 0.150 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2018 | 8 | 0.140 |
Why?
|
| Dacryocystitis | 1 | 2018 | 21 | 0.140 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2021 | 78 | 0.140 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 54 | 0.140 |
Why?
|
| Trichosporon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 396 | 0.140 |
Why?
|
| Opportunistic Infections | 1 | 2018 | 78 | 0.140 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 39 | 0.140 |
Why?
|
| Probiotics | 1 | 2021 | 229 | 0.140 |
Why?
|
| Fungemia | 1 | 2017 | 23 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 899 | 0.140 |
Why?
|
| Granuloma | 1 | 2018 | 63 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2021 | 449 | 0.140 |
Why?
|
| Streptococcus gallolyticus subspecies gallolyticus | 1 | 2017 | 2 | 0.140 |
Why?
|
| Denys-Drash Syndrome | 1 | 2017 | 5 | 0.140 |
Why?
|
| WT1 Proteins | 1 | 2017 | 27 | 0.140 |
Why?
|
| Female | 24 | 2025 | 71382 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2018 | 159 | 0.140 |
Why?
|
| Symbiosis | 1 | 2018 | 102 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 425 | 0.140 |
Why?
|
| Male | 22 | 2025 | 65472 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 174 | 0.130 |
Why?
|
| Parenteral Nutrition | 2 | 2021 | 199 | 0.130 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2017 | 36 | 0.130 |
Why?
|
| Filamins | 1 | 2017 | 27 | 0.130 |
Why?
|
| Diet Therapy | 1 | 2017 | 42 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 464 | 0.130 |
Why?
|
| Bronchogenic Cyst | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 98 | 0.130 |
Why?
|
| Copper | 1 | 2017 | 73 | 0.130 |
Why?
|
| Lacrimal Apparatus | 1 | 2018 | 121 | 0.130 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 29 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 56 | 0.130 |
Why?
|
| Bilirubin | 1 | 2017 | 131 | 0.130 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 37 | 0.130 |
Why?
|
| Esophageal Achalasia | 1 | 2016 | 45 | 0.130 |
Why?
|
| Fundoplication | 1 | 2016 | 68 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2019 | 399 | 0.120 |
Why?
|
| Telomerase | 3 | 2001 | 169 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 237 | 0.120 |
Why?
|
| Branchial Region | 1 | 2015 | 8 | 0.120 |
Why?
|
| Pharyngeal Muscles | 1 | 2015 | 11 | 0.120 |
Why?
|
| Oropharynx | 1 | 2015 | 38 | 0.120 |
Why?
|
| Pharyngeal Diseases | 1 | 2015 | 20 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 139 | 0.120 |
Why?
|
| Polyps | 1 | 2015 | 34 | 0.120 |
Why?
|
| Spermatocele | 1 | 2015 | 2 | 0.120 |
Why?
|
| Infant, Newborn | 6 | 2021 | 8627 | 0.120 |
Why?
|
| Thoracic Wall | 1 | 2015 | 40 | 0.120 |
Why?
|
| Blister | 1 | 2015 | 22 | 0.120 |
Why?
|
| Scrotum | 1 | 2015 | 28 | 0.120 |
Why?
|
| Biological Therapy | 1 | 2015 | 24 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 584 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2021 | 998 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 248 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 239 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 555 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 304 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 128 | 0.110 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 131 | 0.110 |
Why?
|
| Swine Diseases | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 118 | 0.110 |
Why?
|
| Enteritis | 1 | 2013 | 37 | 0.100 |
Why?
|
| Cornea | 1 | 2018 | 595 | 0.100 |
Why?
|
| Hair Diseases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Mast Cells | 1 | 2013 | 71 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 404 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1388 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 209 | 0.100 |
Why?
|
| Microbiota | 2 | 2015 | 441 | 0.100 |
Why?
|
| Eosinophils | 1 | 2013 | 108 | 0.100 |
Why?
|
| Lung Transplantation | 1 | 2017 | 337 | 0.100 |
Why?
|
| Eosinophilia | 1 | 2013 | 86 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 433 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 150 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2021 | 2026 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1770 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 474 | 0.090 |
Why?
|
| Skin | 1 | 2015 | 542 | 0.090 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 90 | 0.090 |
Why?
|
| Graft Survival | 2 | 2024 | 482 | 0.090 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1964 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 361 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 248 | 0.090 |
Why?
|
| Feces | 1 | 2015 | 783 | 0.090 |
Why?
|
| Ceramides | 2 | 2001 | 46 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 4755 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2016 | 520 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 638 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 3360 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 390 | 0.080 |
Why?
|
| Argininosuccinic Aciduria | 2 | 2025 | 56 | 0.080 |
Why?
|
| Stem Cells | 1 | 2015 | 747 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 767 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 353 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2015 | 1139 | 0.070 |
Why?
|
| DNA | 1 | 2014 | 1675 | 0.070 |
Why?
|
| Interleukin-10 | 2 | 2021 | 188 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2024 | 678 | 0.070 |
Why?
|
| Voriconazole | 2 | 2018 | 34 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2024 | 1236 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1849 | 0.070 |
Why?
|
| Soybean Oil | 2 | 2021 | 71 | 0.070 |
Why?
|
| Biomarkers | 3 | 2022 | 3411 | 0.070 |
Why?
|
| Fish Oils | 2 | 2021 | 83 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 509 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17520 | 0.060 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 95 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 893 | 0.060 |
Why?
|
| Antifungal Agents | 2 | 2018 | 306 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 3385 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2025 | 68 | 0.060 |
Why?
|
| Cytokines | 2 | 2021 | 1377 | 0.060 |
Why?
|
| Swine | 2 | 2021 | 1200 | 0.060 |
Why?
|
| Gangliosides | 1 | 2025 | 73 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 1420 | 0.050 |
Why?
|
| Natural Killer T-Cells | 1 | 2025 | 84 | 0.050 |
Why?
|
| CpG Islands | 2 | 2015 | 347 | 0.050 |
Why?
|
| Diet, Western | 1 | 2023 | 17 | 0.050 |
Why?
|
| Allografts | 1 | 2024 | 199 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 24 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 32 | 0.050 |
Why?
|
| Primates | 1 | 2023 | 87 | 0.050 |
Why?
|
| Prednisone | 1 | 2022 | 255 | 0.050 |
Why?
|
| Cough | 1 | 2022 | 96 | 0.050 |
Why?
|
| Amoxicillin | 1 | 2022 | 117 | 0.050 |
Why?
|
| Chest Pain | 1 | 2022 | 132 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 214 | 0.050 |
Why?
|
| Dyspnea | 1 | 2022 | 160 | 0.040 |
Why?
|
| Ileitis | 1 | 2021 | 10 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 156 | 0.040 |
Why?
|
| Emulsions | 1 | 2021 | 70 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2021 | 49 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 426 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 2855 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2021 | 42 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 265 | 0.040 |
Why?
|
| Hyperammonemia | 1 | 2021 | 62 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 4823 | 0.040 |
Why?
|
| Phenotype | 2 | 2023 | 4575 | 0.040 |
Why?
|
| Transfection | 3 | 2014 | 1095 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 80 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 403 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 19 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1039 | 0.040 |
Why?
|
| Serotonin | 1 | 2021 | 222 | 0.040 |
Why?
|
| Ethanol | 1 | 2021 | 166 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 366 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 309 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13093 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 121 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2021 | 496 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 97 | 0.040 |
Why?
|
| Antibodies | 1 | 2001 | 371 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 161 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 159 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 34 | 0.040 |
Why?
|
| Pyloric Antrum | 1 | 2019 | 45 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 322 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9917 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 254 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 66 | 0.040 |
Why?
|
| Lipopeptides | 1 | 2018 | 36 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 47 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 307 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2628 | 0.040 |
Why?
|
| Echinocandins | 1 | 2018 | 44 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 91 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 65 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1084 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2018 | 117 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2018 | 3978 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 65 | 0.040 |
Why?
|
| Febrile Neutropenia | 1 | 2017 | 15 | 0.040 |
Why?
|
| Permeability | 1 | 2018 | 131 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 283 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 120 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2018 | 106 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2018 | 122 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 806 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 115 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 106 | 0.030 |
Why?
|
| Drug Eruptions | 1 | 2017 | 34 | 0.030 |
Why?
|
| Colectomy | 1 | 2018 | 84 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 223 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2018 | 149 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 87 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 345 | 0.030 |
Why?
|
| RNA | 1 | 2001 | 606 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 201 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 1013 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 28911 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 277 | 0.030 |
Why?
|
| Neutropenia | 1 | 2018 | 205 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2001 | 1558 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 1136 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 147 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 220 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1325 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2018 | 536 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 730 | 0.030 |
Why?
|
| Animals, Suckling | 1 | 2015 | 51 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 231 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1757 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1514 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2876 | 0.030 |
Why?
|
| Back | 1 | 2015 | 11 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 825 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 1097 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 1173 | 0.030 |
Why?
|
| Vomiting | 1 | 2015 | 110 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1163 | 0.030 |
Why?
|
| Family | 1 | 2018 | 593 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 354 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 64 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 48 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 35 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 158 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 158 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 748 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2015 | 168 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 37 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 3153 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 3041 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 235 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 100 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 653 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 82 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 252 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 220 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 571 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 546 | 0.020 |
Why?
|
| Adult | 2 | 2025 | 31608 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 439 | 0.020 |
Why?
|
| Endoscopy | 1 | 2013 | 280 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 631 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 456 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 615 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2241 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 504 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 906 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 565 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1118 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10930 | 0.020 |
Why?
|
| Premature Birth | 1 | 2014 | 417 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 6541 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2784 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3131 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3960 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3850 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3863 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1928 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6570 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 4915 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 2144 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2001 | 46 | 0.010 |
Why?
|
| Glucosylceramides | 1 | 2001 | 3 | 0.010 |
Why?
|
| Daunorubicin | 1 | 2001 | 27 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2001 | 46 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2001 | 18 | 0.010 |
Why?
|
| Cholic Acids | 1 | 2001 | 16 | 0.010 |
Why?
|
| Half-Life | 1 | 2001 | 162 | 0.010 |
Why?
|
| Genes, myc | 1 | 2001 | 107 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 136 | 0.010 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2001 | 43 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 2001 | 49 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 62 | 0.010 |
Why?
|
| G1 Phase | 1 | 2001 | 67 | 0.010 |
Why?
|
| Glucosyltransferases | 1 | 2001 | 50 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7586 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 391 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 257 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 218 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 483 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 814 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1714 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 2125 | 0.010 |
Why?
|